Financials in USD. Standardized financial statements.
A compact view of how Ra Medical Systems, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $819,000 | $420,000 | $14,000 | $22,000 | $4.41M | $7.20M | $6.26M | $5.87M | $5.98M |
| Revenue Growth? | +95.0% | +2900.0% | -36.4% | -99.5% | -38.8% | +15.1% | +6.6% | -1.8% | 0.0% |
| Cost of Revenue? | $63,000 | $42,000 | $161,000 | $1.56M | $5.48M | $8.85M | $4.21M | $4.17M | $3.14M |
| Gross Profit? | $756,000 | $378,000 | -$147,000 | -$1.54M | -$1.08M | -$1.65M | $2.05M | $1.71M | $2.84M |
| Gross Margin? | +92.3% | +90.0% | -1050.0% | -6990.9% | -24.4% | -22.9% | +32.8% | +29.0% | +47.5% |
| Operating Expenses? | $21.84M | $11.62M | $22.64M | $27.73M | $34.98M | $56.08M | $33.21M | $19.46M | $7.04M |
| Operating Income? | -$21.08M | -$11.24M | -$26.96M | -$29.27M | -$36.06M | -$57.73M | -$31.16M | -$17.76M | -$4.20M |
| EBITDA? | -$21.08M | -$11.24M | -$18.20M | -$29.27M | -$33.56M | -$54.94M | -$31.16M | -$17.54M | -$4.10M |
| Income Before Tax | -$19.50M | -$13.50M | -$26.86M | -$27.26M | -$36.04M | -$56.94M | -$30.82M | -$17.76M | -$4.20M |
| Income Tax Expense | -$1.81M | $3.14M | $3,000 | $4,000 | $7,000 | $15,000 | $10,000 | $1,000 | $1,000 |
| Net Income? | -$17.18M | -$21.80M | -$26.86M | -$27.26M | -$36.05M | -$56.96M | -$30.83M | -$17.77M | -$4.20M |
| EPS? | $-15.90 | $-6.68 | $-25.98 | $-269.91 | $-1060.77 | $-5416.22 | $-4175.51 | $-1834.66 | $-433.96 |
| Diluted EPS? | $-15.90 | $-6.68 | $-25.98 | $-269.91 | $-1060.77 | $-5416.22 | $-4175.51 | $-1834.66 | $-433.96 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality